Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy

BACKGROUND: Epilepsy affects about 50 million people worldwide and around 30% of these patients have refractory epilepsy, with potential consequences regarding quality of life, morbidity and premature mortality. OBJECTIVE: The aim of treatment with antiseizure medications (ASMs) is to allow patients...

Descripción completa

Detalles Bibliográficos
Autores principales: de MANREZA, Maria Luiza Giraldes, PAN, Tatiane Amaral, CARBONE, Eduardo Quinalha, VATTIMO, Antonio Carlos Amedeo, HERRERA, Renata, MORAIS, Douglas Costa, CARDOSO, Rita Antonelli, de LACERDA, Glenda Corrêa Borges, LIN, Katia, NAKANO, Frederico Nakane, KOWACS, Pedro André, PALMINI, André Luis Fernandes, SOUZA, Adélia Maria de Miranda Henriques, ZUNG, Stevin, YACUBIAN, Elza Márcia Targas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academia Brasileira de Neurologia - ABNEURO 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231438/
https://www.ncbi.nlm.nih.gov/pubmed/34133509
http://dx.doi.org/10.1590/0004-282X-ANP-2020-0082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231438/
https://www.ncbi.nlm.nih.gov/pubmed/34133509
http://dx.doi.org/10.1590/0004-282X-ANP-2020-0082

Ejemplares similares